BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37663929)

  • 1. Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.
    Besschetnova A; Han W; Liu M; Gao Y; Li M; Wang Z; Labaf M; Patalano S; Venkataramani K; Muriph RE; Macoska JA; Siegfried KR; Evans J; Balk SP; Gao S; Han D; Cai C
    Cancer Res Commun; 2023 Aug; 3(8):1716-1730. PubMed ID: 37663929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.
    Watson ZL; Yamamoto TM; McMellen A; Kim H; Hughes CJ; Wheeler LJ; Post MD; Behbakht K; Bitler BG
    Clin Epigenetics; 2019 Nov; 11(1):165. PubMed ID: 31775874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a.
    Vinson DA; Stephens KE; O'Meally RN; Bhat S; Dancy BCR; Cole RN; Yegnasubramanian S; Taverna SD
    Epigenetics Chromatin; 2022 Nov; 15(1):36. PubMed ID: 36411491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Methyltransferases G9a/
    Souza BK; Freire NH; Monteiro TS; Herlinger AL; Jaeger M; Dalmolin MGS; de Farias CB; Gregianin L; Brunetto AT; Brunetto AL; Thiele CJ; Roesler R
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.
    Wang Z; Petricca J; Liu M; Zhang S; Chen S; Li M; Besschetnova A; Patalano S; Venkataramani K; Siegfried KR; Macoska JA; Han D; Gao S; Vedadi M; Arrowsmith CH; He HH; Cai C
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2220472120. PubMed ID: 37549269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy.
    Kang Z; Fu P; Ma H; Li T; Lu K; Liu J; Ginjala V; Romanienko P; Feng Z; Guan M; Ganesan S; Xia B
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites.
    Watanabe S; Iimori M; Chan DV; Hara E; Kitao H; Maehara Y
    Sci Rep; 2018 Jul; 8(1):10888. PubMed ID: 30022091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms.
    Nachiyappan A; Gupta N; Taneja R
    FEBS J; 2022 Mar; 289(5):1329-1351. PubMed ID: 34954891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death.
    Silva-Carvalho AÉ; Alencar APD; Resende MR; da Costa DF; Nonino A; Neves FAR; Saldanha-Araujo F
    Toxicol In Vitro; 2020 Dec; 69():104992. PubMed ID: 32889036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exon resequencing of H3K9 methyltransferase complex genes, EHMT1, EHTM2 and WIZ, in Japanese autism subjects.
    Balan S; Iwayama Y; Maekawa M; Toyota T; Ohnishi T; Toyoshima M; Shimamoto C; Esaki K; Yamada K; Iwata Y; Suzuki K; Ide M; Ota M; Fukuchi S; Tsujii M; Mori N; Shinkai Y; Yoshikawa T
    Mol Autism; 2014; 5(1):49. PubMed ID: 25400900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
    Renneville A; Van Galen P; Canver MC; McConkey M; Krill-Burger JM; Dorfman DM; Holson EB; Bernstein BE; Orkin SH; Bauer DE; Ebert BL
    Blood; 2015 Oct; 126(16):1930-9. PubMed ID: 26320100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration.
    Zhang RH; Judson RN; Liu DY; Kast J; Rossi FM
    Skelet Muscle; 2016; 6():22. PubMed ID: 27239264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics analyses demonstrate a critical role for EHMT1 methyltransferase in transcriptional repression during oogenesis.
    Demond H; Hanna CW; Castillo-Fernandez J; Santos F; Papachristou EK; Segonds-Pichon A; Kishore K; Andrews S; D'Santos CS; Kelsey G
    Genome Res; 2023 Jan; 33(1):18-31. PubMed ID: 36690445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2.
    Leenders R; Zijlmans R; van Bree B; van de Sande M; Trivarelli F; Damen E; Wegert A; Müller D; Ehlert JE; Feger D; Heidemann-Dinger C; Kubbutat M; Schächtele C; Lenstra DC; Mecinović J; Müller G
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2516-2524. PubMed ID: 31350126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cell differentiation and function by the euchromatin histone methyltranserfases G9a and GLP.
    Kramer JM
    Biochem Cell Biol; 2016 Feb; 94(1):26-32. PubMed ID: 26198080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Writers and readers of H3K9me2 form distinct protein networks during the cell cycle that include candidates for H3K9 mimicry.
    Pollin G; De Assuncao TM; Doria Jorge S; Chi YI; Charlesworth MC; Madden B; Iovanna J; Zimmermann MT; Urrutia R; Lomberk G
    Biosci Rep; 2023 Oct; 43(10):. PubMed ID: 37782747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia.
    Pappano WN; Guo J; He Y; Ferguson D; Jagadeeswaran S; Osterling DJ; Gao W; Spence JK; Pliushchev M; Sweis RF; Buchanan FG; Michaelides MR; Shoemaker AR; Tse C; Chiang GG
    PLoS One; 2015; 10(7):e0131716. PubMed ID: 26147105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death.
    Alves-Silva JC; de Carvalho JL; Rabello DA; Serejo TRT; Rego EM; Neves FAR; Lucena-Araujo AR; Pittella-Silva F; Saldanha-Araujo F
    Invest New Drugs; 2018 Oct; 36(5):955-960. PubMed ID: 29855824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease.
    Zheng Y; Liu A; Wang ZJ; Cao Q; Wang W; Lin L; Ma K; Zhang F; Wei J; Matas E; Cheng J; Chen GJ; Wang X; Yan Z
    Brain; 2019 Mar; 142(3):787-807. PubMed ID: 30668640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tri-methylation of ATF7IP by G9a/GLP recruits the chromodomain protein MPP8.
    Tsusaka T; Kikuchi M; Shimazu T; Suzuki T; Sohtome Y; Akakabe M; Sodeoka M; Dohmae N; Umehara T; Shinkai Y
    Epigenetics Chromatin; 2018 Oct; 11(1):56. PubMed ID: 30286792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.